APO Research
Talk to an analyst

APO RESEARCH · REPORT

Porcine Circovirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Porcine Circovirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchPorcine Circovirus Vaccine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Circovirus Vaccine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Porcine Circovirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Circovirus Vaccine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Circovirus Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Porcine Circovirus Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Porcine Circovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Porcine Circovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Porcine Circovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Porcine Circovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Porcine Circovirus Vaccine include Zoetis, Ringpu Biology, Qilu Animal, Jinyu Bio-Technology, ChengDu Tecbond, Komipharm, DHN, Chopper Biology and CAVAC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Porcine Circovirus Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Porcine Circovirus Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Porcine Circovirus Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Porcine Circovirus Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Porcine Circovirus Vaccine Segment by Company

Zoetis

Ringpu Biology

Qilu Animal

Jinyu Bio-Technology

ChengDu Tecbond

Komipharm

DHN

Chopper Biology

CAVAC

Boehringer Ingelheim

Porcine Circovirus Vaccine Segment by Type

Genetic Engineering Vaccine

Killed Vaccines

Porcine Circovirus Vaccine Segment by Application

Piglets

Adults Pigs

Porcine Circovirus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Circovirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Circovirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Circovirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Porcine Circovirus Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Porcine Circovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Porcine Circovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Porcine Circovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Porcine Circovirus Vaccine Industry Trends Table 2. Porcine Circovirus Vaccine Industry Drivers Table 3. Porcine Circovirus Vaccine Industry Opportunities and Challenges Table 4. Porcine Circovirus Vaccine Industry Restraints Table 5. Global Porcine Circovirus Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Porcine Circovirus Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Porcine Circovirus Vaccine Sales by Manufacturers (m units) & (2021-2026) Table 8. Global Porcine Circovirus Vaccine Sales Market Share by Manufacturers Table 9. Global Porcine Circovirus Vaccine Average Sales Price (US$/k unit) of Manufacturers (2021-2026) Table 10. Global Porcine Circovirus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Porcine Circovirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Porcine Circovirus Vaccine Manufacturers, Product Type & Application Table 13. Global Porcine Circovirus Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Porcine Circovirus Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Genetic Engineering Vaccine Table 17. Major Manufacturers of Killed Vaccines Table 18. Global Porcine Circovirus Vaccine Sales by Type 2021 VS 2025 VS 2032 (m units) Table 19. Global Porcine Circovirus Vaccine Sales by Type (2021-2026) & (m units) Table 20. Global Porcine Circovirus Vaccine Sales by Type (2027-2032) & (m units) Table 21. Global Porcine Circovirus Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Porcine Circovirus Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Porcine Circovirus Vaccine Revenue by Type 2021 VS 2025 VS 2032 (m units) Table 24. Global Porcine Circovirus Vaccine Revenue by Type (2021-2026) & (m units) Table 25. Global Porcine Circovirus Vaccine Revenue by Type (2027-2032) & (m units) Table 26. Global Porcine Circovirus Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Porcine Circovirus Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Piglets Table 29. Major Manufacturers of Adults Pigs Table 30. Global Porcine Circovirus Vaccine Sales by Application 2021 VS 2025 VS 2032 (m units) Table 31. Global Porcine Circovirus Vaccine Sales by Application (2021-2026) & (m units) Table 32. Global Porcine Circovirus Vaccine Sales by Application (2027-2032) & (m units) Table 33. Global Porcine Circovirus Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Porcine Circovirus Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Porcine Circovirus Vaccine Revenue by Application 2021 VS 2025 VS 2032 (m units) Table 36. Global Porcine Circovirus Vaccine Revenue by Application (2021-2026) & (m units) Table 37. Global Porcine Circovirus Vaccine Revenue by Application (2027-2032) & (m units) Table 38. Global Porcine Circovirus Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Porcine Circovirus Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Porcine Circovirus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (m units) Table 41. Global Porcine Circovirus Vaccine Sales by Region (2021-2026) & (m units) Table 42. Global Porcine Circovirus Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Porcine Circovirus Vaccine Sales Forecasted by Region (2027-2032) & (m units) Table 44. Global Porcine Circovirus Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Porcine Circovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 46. North America Porcine Circovirus Vaccine Sales by Country (2021-2026) & (m units) Table 47. North America Porcine Circovirus Vaccine Sales by Country (2027-2032) & (m units) Table 48. Europe Porcine Circovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 49. Europe Porcine Circovirus Vaccine Sales by Country (2021-2026) & (m units) Table 50. Europe Porcine Circovirus Vaccine Sales by Country (2027-2032) & (m units) Table 51. Asia Pacific Porcine Circovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 52. Asia Pacific Porcine Circovirus Vaccine Sales by Country (2021-2026) & (m units) Table 53. Asia Pacific Porcine Circovirus Vaccine Sales by Country (2027-2032) & (m units) Table 54. South America, Middle East and Africa Porcine Circovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 55. South America, Middle East and Africa Porcine Circovirus Vaccine Sales by Country (2021-2026) & (m units) Table 56. South America, Middle East and Africa Porcine Circovirus Vaccine Sales by Country (2027-2032) & (m units) Table 57. Global Porcine Circovirus Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Porcine Circovirus Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Porcine Circovirus Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Porcine Circovirus Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Porcine Circovirus Vaccine Revenue Market Share by Region (2027-2032) Table 62. Zoetis Company Information Table 63. Zoetis Business Overview Table 64. Zoetis Porcine Circovirus Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Zoetis Porcine Circovirus Vaccine Product Portfolio Table 66. Zoetis Recent Development Table 67. Ringpu Biology Company Information Table 68. Ringpu Biology Business Overview Table 69. Ringpu Biology Porcine Circovirus Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Ringpu Biology Porcine Circovirus Vaccine Product Portfolio Table 71. Ringpu Biology Recent Development Table 72. Qilu Animal Company Information Table 73. Qilu Animal Business Overview Table 74. Qilu Animal Porcine Circovirus Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Qilu Animal Porcine Circovirus Vaccine Product Portfolio Table 76. Qilu Animal Recent Development Table 77. Jinyu Bio-Technology Company Information Table 78. Jinyu Bio-Technology Business Overview Table 79. Jinyu Bio-Technology Porcine Circovirus Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Jinyu Bio-Technology Porcine Circovirus Vaccine Product Portfolio Table 81. Jinyu Bio-Technology Recent Development Table 82. ChengDu Tecbond Company Information Table 83. ChengDu Tecbond Business Overview Table 84. ChengDu Tecbond Porcine Circovirus Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. ChengDu Tecbond Porcine Circovirus Vaccine Product Portfolio Table 86. ChengDu Tecbond Recent Development Table 87. Komipharm Company Information Table 88. Komipharm Business Overview Table 89. Komipharm Porcine Circovirus Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Komipharm Porcine Circovirus Vaccine Product Portfolio Table 91. Komipharm Recent Development Table 92. DHN Company Information Table 93. DHN Business Overview Table 94. DHN Porcine Circovirus Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. DHN Porcine Circovirus Vaccine Product Portfolio Table 96. DHN Recent Development Table 97. Chopper Biology Company Information Table 98. Chopper Biology Business Overview Table 99. Chopper Biology Porcine Circovirus Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Chopper Biology Porcine Circovirus Vaccine Product Portfolio Table 101. Chopper Biology Recent Development Table 102. CAVAC Company Information Table 103. CAVAC Business Overview Table 104. CAVAC Porcine Circovirus Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. CAVAC Porcine Circovirus Vaccine Product Portfolio Table 106. CAVAC Recent Development Table 107. Boehringer Ingelheim Company Information Table 108. Boehringer Ingelheim Business Overview Table 109. Boehringer Ingelheim Porcine Circovirus Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Boehringer Ingelheim Porcine Circovirus Vaccine Product Portfolio Table 111. Boehringer Ingelheim Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Porcine Circovirus Vaccine Distributors List Table 115. Porcine Circovirus Vaccine Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Porcine Circovirus Vaccine Product Image Figure 2. Global Porcine Circovirus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Porcine Circovirus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Porcine Circovirus Vaccine Sales (2021-2032) & (m units) Figure 5. Global Porcine Circovirus Vaccine Average Price (US$/k unit) & (2021-2032) Figure 6. Global Top 5 and 10 Porcine Circovirus Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Genetic Engineering Vaccine Image Figure 9. Killed Vaccines Image Figure 10. Global Porcine Circovirus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (m units) Figure 11. Global Porcine Circovirus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Porcine Circovirus Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Porcine Circovirus Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (m units) Figure 14. Global Porcine Circovirus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Porcine Circovirus Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Piglets Image Figure 17. Adults Pigs Image Figure 18. Global Porcine Circovirus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (m units) Figure 19. Global Porcine Circovirus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Porcine Circovirus Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Porcine Circovirus Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (m units) Figure 22. Global Porcine Circovirus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Porcine Circovirus Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 25. North America Porcine Circovirus Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 27. Canada Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 28. Mexico Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 29. Europe Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 30. Europe Porcine Circovirus Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 32. France Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 33. U.K. Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 34. Italy Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 35. Netherlands Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 36. Asia Pacific Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 37. Asia Pacific Porcine Circovirus Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 39. Japan Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 40. South Korea Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 41. Southeast Asia Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 42. India Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 43. Australia Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 44. South America, Middle East and Africa Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 45. South America, Middle East and Africa Porcine Circovirus Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 47. South Africa Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 48. Saudi Arabia Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 49. Turkey Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 50. Argentina Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 51. UAE Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 52. Egypt Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 53. Chile Porcine Circovirus Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 54. Global Porcine Circovirus Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Porcine Circovirus Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Porcine Circovirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Porcine Circovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Porcine Circovirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Porcine Circovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Porcine Circovirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Porcine Circovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Porcine Circovirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Porcine Circovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Porcine Circovirus Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Porcine Circovirus Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Genetic Engineering Vaccine
  • Killed Vaccines
Applications
  • Piglets
  • Adults Pigs
Companies covered
  • Zoetis
  • Ringpu Biology
  • Qilu Animal
  • Jinyu Bio-Technology
  • ChengDu Tecbond
  • Komipharm
  • DHN
  • Chopper Biology
  • CAVAC
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Porcine Circovirus Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Porcine Circovirus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Porcine Circovirus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Porcine Circovirus Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Porcine Circovirus Vaccine Market Dynamics
  1. 2.1 Porcine Circovirus Vaccine Industry Trends
  2. 2.2 Porcine Circovirus Vaccine Industry Drivers
  3. 2.3 Porcine Circovirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Porcine Circovirus Vaccine Industry Restraints
3 Porcine Circovirus Vaccine Market by Manufacturers
  1. 3.1 Global Porcine Circovirus Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Porcine Circovirus Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Porcine Circovirus Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Porcine Circovirus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Porcine Circovirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Porcine Circovirus Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Porcine Circovirus Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Porcine Circovirus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Porcine Circovirus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Porcine Circovirus Vaccine Tier 1, Tier 2, and Tier 3
4 Porcine Circovirus Vaccine Market by Type
  1. 4.1 Porcine Circovirus Vaccine Type Introduction
  2. 4.1.1 Genetic Engineering Vaccine
  3. 4.1.2 Killed Vaccines
  4. 4.2 Global Porcine Circovirus Vaccine Sales by Type
  5. 4.2.1 Global Porcine Circovirus Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Porcine Circovirus Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Porcine Circovirus Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Porcine Circovirus Vaccine Revenue by Type
  9. 4.3.1 Global Porcine Circovirus Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Porcine Circovirus Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Porcine Circovirus Vaccine Revenue Market Share by Type (2021-2032)
5 Porcine Circovirus Vaccine Market by Application
  1. 5.1 Porcine Circovirus Vaccine Application Introduction
  2. 5.1.1 Piglets
  3. 5.1.2 Adults Pigs
  4. 5.2 Global Porcine Circovirus Vaccine Sales by Application
  5. 5.2.1 Global Porcine Circovirus Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Porcine Circovirus Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Porcine Circovirus Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Porcine Circovirus Vaccine Revenue by Application
  9. 5.3.1 Global Porcine Circovirus Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Porcine Circovirus Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Porcine Circovirus Vaccine Revenue Market Share by Application (2021-2032)
6 Global Porcine Circovirus Vaccine Sales by Region
  1. 6.1 Global Porcine Circovirus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Porcine Circovirus Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Porcine Circovirus Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Porcine Circovirus Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Porcine Circovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Porcine Circovirus Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Porcine Circovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Porcine Circovirus Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Porcine Circovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Porcine Circovirus Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Porcine Circovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Porcine Circovirus Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Porcine Circovirus Vaccine Revenue by Region
  1. 7.1 Global Porcine Circovirus Vaccine Revenue by Region
  2. 7.1.1 Global Porcine Circovirus Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Porcine Circovirus Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Porcine Circovirus Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Porcine Circovirus Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Porcine Circovirus Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Porcine Circovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Porcine Circovirus Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Porcine Circovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Porcine Circovirus Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Porcine Circovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Porcine Circovirus Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Porcine Circovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Porcine Circovirus Vaccine Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Ringpu Biology
  8. 8.2.1 Ringpu Biology Company Information
  9. 8.2.2 Ringpu Biology Business Overview
  10. 8.2.3 Ringpu Biology Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ringpu Biology Porcine Circovirus Vaccine Product Portfolio
  12. 8.2.5 Ringpu Biology Recent Developments
  13. 8.3 Qilu Animal
  14. 8.3.1 Qilu Animal Company Information
  15. 8.3.2 Qilu Animal Business Overview
  16. 8.3.3 Qilu Animal Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Animal Porcine Circovirus Vaccine Product Portfolio
  18. 8.3.5 Qilu Animal Recent Developments
  19. 8.4 Jinyu Bio-Technology
  20. 8.4.1 Jinyu Bio-Technology Company Information
  21. 8.4.2 Jinyu Bio-Technology Business Overview
  22. 8.4.3 Jinyu Bio-Technology Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jinyu Bio-Technology Porcine Circovirus Vaccine Product Portfolio
  24. 8.4.5 Jinyu Bio-Technology Recent Developments
  25. 8.5 ChengDu Tecbond
  26. 8.5.1 ChengDu Tecbond Company Information
  27. 8.5.2 ChengDu Tecbond Business Overview
  28. 8.5.3 ChengDu Tecbond Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ChengDu Tecbond Porcine Circovirus Vaccine Product Portfolio
  30. 8.5.5 ChengDu Tecbond Recent Developments
  31. 8.6 Komipharm
  32. 8.6.1 Komipharm Company Information
  33. 8.6.2 Komipharm Business Overview
  34. 8.6.3 Komipharm Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Komipharm Porcine Circovirus Vaccine Product Portfolio
  36. 8.6.5 Komipharm Recent Developments
  37. 8.7 DHN
  38. 8.7.1 DHN Company Information
  39. 8.7.2 DHN Business Overview
  40. 8.7.3 DHN Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 DHN Porcine Circovirus Vaccine Product Portfolio
  42. 8.7.5 DHN Recent Developments
  43. 8.8 Chopper Biology
  44. 8.8.1 Chopper Biology Company Information
  45. 8.8.2 Chopper Biology Business Overview
  46. 8.8.3 Chopper Biology Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Chopper Biology Porcine Circovirus Vaccine Product Portfolio
  48. 8.8.5 Chopper Biology Recent Developments
  49. 8.9 CAVAC
  50. 8.9.1 CAVAC Company Information
  51. 8.9.2 CAVAC Business Overview
  52. 8.9.3 CAVAC Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CAVAC Porcine Circovirus Vaccine Product Portfolio
  54. 8.9.5 CAVAC Recent Developments
  55. 8.10 Boehringer Ingelheim
  56. 8.10.1 Boehringer Ingelheim Company Information
  57. 8.10.2 Boehringer Ingelheim Business Overview
  58. 8.10.3 Boehringer Ingelheim Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim Porcine Circovirus Vaccine Product Portfolio
  60. 8.10.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Porcine Circovirus Vaccine Value Chain Analysis
  2. 9.1.1 Porcine Circovirus Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Porcine Circovirus Vaccine Production Mode & Process
  6. 9.2 Porcine Circovirus Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Porcine Circovirus Vaccine Distributors
  9. 9.2.3 Porcine Circovirus Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst